The IPBS participates in a newly funded European Twinning for Excellence project to advance research in the activation of anti-tumor immunity
More than a decade has passed since the first immune checkpoint inhibitor (ICI) was approved[…]
More than a decade has passed since the first immune checkpoint inhibitor (ICI) was approved[…]
This hybrid EMBO workshop was organized by Dr. Priyanka Sharma, with co-organizers Dr. Michel Simon[…]
On June 5, Wendy Le Mouëllc won the first jury’s prize at the MT180 2024[…]
Born from a scientific collaboration between the Institute of Pharmacology and Structural Biology (IPBS –[…]
IPBS invites its community to embrace gender, sexual and ethnic diversity throughout the year, highlighting[…]
Tumor-associated HEVs (TA-HEVs) function as portals of entry for lymphocytes into tumors during cancer immunotherapy.[…]
Saurabh Chugh is awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Individual Fellowship to study the[…]
“Ma thèse en 180 secondes” enables doctoral students to present their research topic, in French[…]
As part of the international research network (IRN) MIRA (Emerging Infectious Diseases and Antibiotic Resistance)[…]
The IPBS-Toulouse launches its annual call for the recruitment of new group leaders. As a[…]